10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $324,473 | -57.5% | 7,866 | -42.4% | 0.00% | -100.0% |
| Q2 2023 | $763,193 | +82.3% | 13,668 | +82.1% | 0.00% | – |
| Q1 2023 | $418,648 | -25.2% | 7,504 | -51.1% | 0.00% | – |
| Q4 2022 | $559,700 | +6.6% | 15,360 | -16.6% | 0.00% | -100.0% |
| Q3 2022 | $525,000 | -46.2% | 18,427 | -14.6% | 0.00% | 0.0% |
| Q2 2022 | $976,000 | -35.6% | 21,573 | +8.3% | 0.00% | 0.0% |
| Q1 2022 | $1,515,000 | -37.6% | 19,913 | +22.2% | 0.00% | -50.0% |
| Q4 2021 | $2,428,000 | +87.9% | 16,302 | +83.6% | 0.00% | +100.0% |
| Q3 2021 | $1,292,000 | -31.5% | 8,877 | -7.8% | 0.00% | -50.0% |
| Q2 2021 | $1,885,000 | +15.7% | 9,628 | +7.0% | 0.00% | 0.0% |
| Q1 2021 | $1,629,000 | +63.7% | 8,999 | +28.1% | 0.00% | +100.0% |
| Q4 2020 | $995,000 | +126.7% | 7,027 | +99.4% | 0.00% | 0.0% |
| Q3 2020 | $439,000 | – | 3,524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |